HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$10.15
Day range
$9.79 - $10.17
Year range
$9.79 - $18.89
Market cap
991.23M USD
Avg Volume
2.63M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 15.72M | 3,043.40% |
Operating expense | 54.31M | 507.25% |
Net income | -44.88M | -258.60% |
Net profit margin | -285.57 | 88.59% |
Earnings per share | -0.46 | -253.85% |
EBITDA | -47.34M | -208.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 240.13M | 9.78% |
Total assets | 313.47M | 41.23% |
Total liabilities | 121.15M | 1,701.50% |
Total equity | 192.32M | — |
Shares outstanding | 98.83M | — |
Price to book | 5.21 | — |
Return on assets | -37.15% | — |
Return on capital | -42.18% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -44.88M | -258.60% |
Cash from operations | -39.59M | -443.92% |
Cash from investing | 48.57M | 484.08% |
Cash from financing | 2.70M | 394.86% |
Net change in cash | 11.68M | 160.25% |
Free cash flow | -19.87M | -676.09% |
About
Founded
2015
Website
Employees
165
